ELEKTA AB/ADR (OTCMKTS:EKTAY) – Stock analysts at Jefferies Financial Group issued their FY2019 EPS estimates for shares of ELEKTA AB/ADR in a note issued to investors on Tuesday, December 4th. Jefferies Financial Group analyst K. Lee anticipates that the company will post earnings per share of $0.39 for the year. Jefferies Financial Group also issued estimates for ELEKTA AB/ADR’s FY2020 earnings at $0.45 EPS, FY2021 earnings at $0.51 EPS and FY2022 earnings at $0.57 EPS.
Several other equities research analysts also recently commented on the stock. Zacks Investment Research downgraded shares of ELEKTA AB/ADR from a “buy” rating to a “hold” rating in a report on Tuesday, August 14th. UBS Group raised shares of ELEKTA AB/ADR from a “neutral” rating to a “buy” rating in a report on Wednesday, November 28th.
About ELEKTA AB/ADR
Elekta AB (publ) provides equipment and software for cancer and brain disorders worldwide. The company offers radiotherapy systems under the Versa HD, Precise Treatment System, and Elekta Compact names; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.
See Also: What is a balanced fund?
Receive News & Ratings for ELEKTA AB/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEKTA AB/ADR and related companies with MarketBeat.com's FREE daily email newsletter.